US 2016/0243154 A1Published application

Hyaluronic acid formulation

OwnerDonald W. Jessup, Donald W. Grove, Jr.inventors

Life of this patent

Estimating the term…

Abstract

The present invention provides solid formulations of hyaluronic acid (HA) that are resistant to degradation into low molecular weight species of HA and yet can be readily dissolved in water. The compositions comprise sodium hyaluronate, cyclo-dextrin, sodium benzoate, and potassium sorbate, wherein said composition is in powder form.

Claims62

Dependent claims

A composition comprising sodium hyaluronate, cyclodextrin, and potassium sorbate, wherein said composition is in powder form.

Dependencies are inferred from the claim text.

Facts

Application: 15/031,652Filed 23 Oct 2014
Priority: 23 Oct 2013
Published: 25 Aug 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 31/728
Glycosaminoglycans, i.e. mucopolysaccharides: hyaluronic acid
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/08
Medicinal preparations characterised by special physical form: solutions

Family

Application61/894,818Us provisional application · filed 23 Oct 2013
US 2016/0243154 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results